Drugs established for other health conditions may provide cancer benefit
Drugs that control blood pressure and lower cholesterol, among others, nay help patients derive greater benefit from cancer treatment....
11 March, 2022
Author: UW CTI
UW plays a leading role in vaccine clinical trials in the fight against COVID-19
In a little over 18 months, UW-Madison has conducted COVID vaccine and treatment trials in all age groups (ages 7 months- 96 years old). These trials are a representation of all people (race, religion, sex) in Wisconsin- nearly 700 participants....
01 March, 2022
Rare Disease Day: Six clinical trial stories you need to read
New clinical trial design strategies could spell a more promising future in rare disease drug development. ...
28 February, 2022
Patient diversity in clinical studies: The key to advancing precision medicine
Until we have better inclusion of participants with diverse demographics and behaviors – and can analyze that data in conjunction with prognostic data – we won’t know the effectiveness of a product for these large, underrepresented populations....
22 February, 2022
Physician reflects on improving equity in healthcare through her work with patients, students and trainees
During Black History Month, UW Health's Dr. Jacqueline Peebles is thinking about how to influence and improve equity in healthcare at every stage....
14 February, 2022
Diversity in dermatology clinical trials remains unchanged over last decade
A systematic review reveals that although the reporting of racial and ethnic data has increased in recent years, inclusion of minority groups in dermatological clinical trials has remained unchanged....
04 February, 2022
Addressing research for women from every angle
When sponsors develop drugs and devices specifically for women, they need to create clinical trials that are uniquely female-focused. From protocols and endpoints, to recruiting strategies and messaging, these trials have to take into account the unique needs, expectations and regulatory requirements of a totally...
04 February, 2022
The Importance of Patient Diversity in Clinical Trials
Clinical trials drive progress forward. They give patients early access to new treatments that lead to better outcomes. Yet racial and ethnic minorities are underrepresented in clinical research, according to the FDA....
05 January, 2022
FDA releases their first public Notice of Noncompliance to a Principal Investigator
The first public notice of noncompliance was sent out to a Principal Investigator at an Academic Medical Center....
31 August, 2021